• Research
    • Our Mission
    • Multidrug Therapies
    • Surveillance
    • Stewardship
    • Education & Outreach
    • Publications
  • Resources & Services
    • Drug Combinations Lab
    • Levy CIMAR Summer Internship
    • AMR Pre-College Program
    • Educational Resources
    • For Levy CIMAR Faculty
    • Our Values
  • Publications
  • People
    • Leadership
    • Core Faculty
    • Affiliate Members
    • Featured Trainees
    • About Stuart B. Levy, M.D. 
  • News
    • Upcoming Events
    • Levy CIMAR in the News
    • Press Releases
  • Giving
  • Contact

Effect of In-Line Drinking Water Chlorination at the Point of Collection on Childdiarrhoea in Urban Bangladesh: A Double-Blind, Cluster-Randomised Controlled Trial

by Levy CIMAR | Sep 1, 2019 | Publications

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections

by Levy CIMAR | Aug 10, 2019 | Publications

Acinetobacter baumannii: Envelope determinants that control drug resistance, virulence, and surface variability

by Levy CIMAR | Jun 14, 2019 | Publications

Erica Fuhrmeister, PhD, Postdoctoral Scholar and National Science Foundation Fellow

by Levy CIMAR | Jun 9, 2019 | Trainees

Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS)

by Levy CIMAR | May 17, 2019 | Publications

Page 74 of 86« First«...102030...7273747576...80...»Last »

Recent Posts

  • EXPRESS: Factors associated with antimicrobial drug prescription in cats receiving outpatient care at a veterinary teaching hospital
  • Loss of essential outer membrane functions causes drug hypersensitization in Acinetobacter baumannii overexpressing multidrug efflux pumps
  • Growth arrest of Mycobacterium tuberculosis in acidic environments enhances their survival of antibiotic treatment
  • Point-Counterpoint: The “obsoletogram”—are annual hospital antibiograms still relevant?
  • Species-level reporting of Coagulase-negative staphylococci with MALDI-TOF does not impact clinical outcomes

The Levy CIMAR is a collaboration of Tufts Medical Center and the Tufts University Office of the Vice Provost for Research (OVPR) Research and Scholarship Strategic Plan (RSSP).

Contact us



South Cove 502, 136 Harrison Ave. Boston, MA. 02111



(617) 636-3824



CIMAR@tufts.edu

Join the CIMAR mailing list

Stay updated with our latest research, events and news.

© 2026 LevyCIMAR. All Rights Reserved.